📢 Product Launch Announcement: Ondoforce MD 4

We are proud to announce the launch of Ondoforce MD 4, an advanced orally disintegrating formulation of Ondansetron 4 mg, specifically designed for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative recovery.

Ondoforce MD 4 combines clinical reliability with patient-friendly innovation, offering healthcare professionals a trusted and effective solution to manage emesis in various clinical settings.

🔹 About Ondoforce MD 4

• Active Ingredient: Ondansetron 4 mg (Orally Disintegrating)
• Therapeutic Class: Anti-Emetic / 5-HT₃ Receptor Antagonist
• Primary Indications:
  • Prevention and treatment of nausea and vomiting associated with:
    • Chemotherapy-induced nausea and vomiting (CINV)
    • Radiotherapy-induced nausea and vomiting (RINV)
    • Postoperative nausea and vomiting (PONV)
• Mechanism of Action:
  Ondansetron selectively blocks serotonin 5-HT₃ receptors in the central nervous system and gastrointestinal tract, effectively preventing the initiation of the vomiting reflex.

🔹 Key Features & Benefits

✅ Rapid Disintegration, No Water Needed

• Designed for immediate melting on the tongue, making administration easy, especially for pediatric, elderly, or nauseous patients.

✅ Clinically Proven Efficacy

• Widely recognized and trusted in oncology, surgical, and critical care settings for superior anti-emetic control.

✅ Patient-Friendly Format

• Ideal for patients with difficulty swallowing or those at risk of vomiting post-administration.

✅ Reliable Safety Profile

• Well-tolerated with minimal side effects, ensuring safe use across diverse patient groups.

✅ Enhanced Compliance and Comfort

• Improves patient experience and adherence, contributing to better overall therapeutic outcomes.

🏥 Hospitals, Oncology Centers, Surgical Units

• Essential anti-emetic support across intensive and outpatient care settings.

👨‍⚕️ Oncologists, Anesthesiologists, General Surgeons, Physicians

• Equipping healthcare professionals with a reliable first-line anti-emetic option.

🧑‍🤝‍🧑 Patients Undergoing Chemotherapy, Radiotherapy, or Surgery

• Providing fast-acting relief to reduce the burden of treatment-related nausea and vomiting.

🔹 Our Commitment

At Green Apple Pharmaceuticals Private Limited, we believe in combining medical innovation with patient-centric care.
With Ondoforce MD 4, we reinforce our commitment to delivering cutting-edge, trusted solutions that improve quality of life and clinical outcomes.

Ondoforce MD 4 — Advanced Care for Every Patient, Every Time.

📦 Now Available

For detailed prescribing information, clinical usage guidelines, or support materials, please contact our medical team or visit Ondoforce MD 4.